Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Study of the Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma.

NCT06416683 is registered in ClinicalTrials.gov with University Hospital, Caen as lead sponsor.

NCT NCT06416683
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06416683 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Study of the Atezolizumab and Bevacizumab Combination Recommended in a Multidisciplinary Consultation Meeting in Caen for Hepatocellular Carcinoma.
Lead sponsor
University Hospital, Caen
Phase
Observational
Overall status
Completed
Start date
January 1, 2021
Completion date
January 30, 2024
Enrollment
109 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

atezolizumab and bevacizumab in hepatocellular carcinoma